Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients

ConclusionMultiple doses of evocalcet reduced intact PTH levels with a concomitant decrease in serum calcium levels. Evocalcet was well tolerated in SHPT patients receiving hemodialysis.

Source: Clinical and Experimental Nephrology - August 29, 2018 Category: Urology & Nephrology Source Type: research